Storm Chase study for immediate protection to covid-19 exposure.
Scientists from the University College London Hospitals of NHS Britain are working on the possible treatment based on antibody developed by AstraZeneca under Strom chase study in its clinical trials.
The research will certainly help those people who have been exposed to the coronavirus by providing a monoclonal antibody that neutralizes the virus.
The drug named AZD7442 has been developed by AstraZeneca, a UK pharma leader in developing coronavirus vaccine.
This novel drug may help to provide protection against the people for about one year before everybody gets vaccination.
AZD7442 is in clinical phase 3 trial and it seems to be a new ray of hope for a healthy 2021.